Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Shalini R: Not All Blood Thinners Are the Same
Shalini R/LinkedIn
Apr 23, 2026, 17:57

Shalini R: Not All Blood Thinners Are the Same

Shalini R, Registered Nurse at Saudi German Health, shared a post on LinkedIn:

”Notes:10

Not all ‘blood thinners’ are the same – and understanding the difference is key to safer prescribing and better patient outcomes.

This visual highlights the distinction between anticoagulants and antiplatelet agents, two major classes that reduce clot formation through different mechanisms:

Anticoagulants (e.g., warfarin, apixaban, rivaroxaban, dabigatran)

  • Work on the coagulation cascade to slow down clot formation
  • Commonly used in conditions like atrial fibrillation, DVT, and PE
  • Require careful monitoring (especially warfarin)
  • Associated with a higher bleeding risk

Antiplatlet drugs (e.g., aspirin, clopidogrel, ticagrelor, prasugrel)

  • Prevent platelets from aggregating and forming clots
  • Primarily used in arterial disease (e.g., coronary artery disease, stroke prevention)
  • Typically lower bleeding risk compared to anticoagulants

Key takeaway:

Anticoagulants target the clotting cascade, while antiplatelets target platelet function-choosing the right class depends on the underlying pathology.

A simple concept, but one that makes a critical difference in clinical decision-making.”

Shalini R: Not All Blood Thinners Are the Same

Stay updated with Hemostasis Today.

Apixaban Aspirin bleeding disorders Blood Thinners clopidogrel Coronary Artery Disease dabigatran Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine prasugrel Rivaroxaban Shalini R ticagrelor Warfarin
NewsFeed